Registers up to 650,000 Shares for Warrants Issued to Lender
RCEL sits 35% above its 52-week low of $3.22.
Summary
AVITA Medical registered up to 650,000 shares of common stock underlying warrants issued to Perceptive Credit Holdings V, LP, enabling the lender to exercise these warrants at $3.4019 per share.
Key Events · Financing and Capital Events · RCEL
-
Warrant Share Registration
AVITA Medical registered up to 650,000 shares of common stock underlying warrants issued to Perceptive Credit Holdings V, LP.
-
Exercise Price Below Market
The warrants have an exercise price of $3.4019 per share, which is approximately 21.5% below the current market price of $4.3389.
-
Potential Dilution
The registration enables potential dilution of approximately 2.11% of current outstanding shares if all warrants are exercised.
-
Proceeds Not Relied Upon
The company may receive up to $2.2 million if warrants are fully exercised for cash, but does not expect to rely on these proceeds for operations.
Analysis · RCEL · Industrial Applications And Services
This filing registers shares associated with warrants granted to Perceptive Credit Holdings V, LP as part of a previously disclosed $60 million credit facility. While the credit facility is crucial for AVITA Medical, which has a 'going concern' warning, the registration of these warrants enables potential dilution of up to 2.11% of outstanding shares. The exercise price of $3.4019 is below the current market price, making future exercise more likely and potentially dilutive for existing shareholders. The company does not expect to rely on the potential $2.2 million in cash proceeds from warrant exercise for its operations.
At the time of this filing, RCEL was trading at $4.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $128.6M. The 52-week trading range was $3.22 to $7.12. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.